Fabrizio Gasparini
Basel, BS, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Brain pathology in relation to somatic diseases: Exploring the body-brain crosstalk.
Journal: Journal of internal medicine
Published: June 02, 2026
Mavoglurant reduces cocaine use in patients with cocaine use disorder in a phase 2 clinical trial.
Journal: Science translational medicine
Published: April 02, 2025
Multiparametric MRI assessment of acute neuroinflammation in a murine model of peripheral LPS stimulation.
Journal: BMC medical imaging
Published: March 31, 2025
Central and Peripheral Inflammation in Mild Cognitive Impairment in the Context of Alzheimer's Disease.
Journal: International journal of molecular sciences
Published: May 11, 2023
Genetic models of cleavage-reduced and soluble TREM2 reveal distinct effects on myelination and microglia function in the cuprizone model.
Journal: Journal of neuroinflammation
Published: July 13, 2022
Regional brain mGlu5 receptor occupancy following single oral doses of mavoglurant as measured by [11C]-ABP688 PET imaging in healthy volunteers.
Journal: NeuroImage
Published: September 07, 2020
Drug repurposing: Old drugs, new tricks to fast track drug development for the brain.
Journal: Neuropharmacology
Published: January 15, 2019
Protein synthesis levels are increased in a subset of individuals with fragile X syndrome.
Journal: Human molecular genetics
Published: June 20, 2018
Protein synthesis levels are increased in a subset of individuals with fragile X syndrome.
Journal: Human molecular genetics
Published: January 24, 2018
Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome.
Journal: Nature reviews. Drug discovery
Published: December 09, 2017
Last Updated: 09/26/2026